By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Sigma-Aldrich today reported that its first-quarter revenues increased 10 percent year over year, with particularly strong growth from its SAFC business unit.

The St. Louis-based chemicals and research products firm reported total sales of $623 million, up 10 percent from $569 million for the first quarter of 2010. On an organic basis, the firm's sales were up 7 percent year over year, and it beat analysts' consensus estimate of $602.9 million.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

A research duo estimates in PLOS One the number of papers that have used misidentified cell lines.

UK's National Institute for Health and Care Excellence approves GlaxoSmithKline's SCID gene therapy despite cost.

Science reports that Brazilian researchers are petitioning for the reversal of budget cuts.

In PLOS this week: gene flow patterns in common ash, guidelines for using morpholinos in zebrafish, and more.